Insider selling
Traded Mar 23 · filed 1 day laterNot reported under a pre-arranged trading plan
Viatris's See Remarks sold $284K of Viatris shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 27, 2025 · Filed Mar 10, 2026
A Viatris director paid $3K out of pocket for Viatris shares. 1 other person at Viatris bought some too, in the same month. It was the first purchase in over a year.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$2,981
Shares × reported transaction price
<$25K
+41.8%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 56 months of history
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
20 days after results of Aug 7, 2025, 71 days before results of Nov 6, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
David S Simmons's first open-market purchase of VTRS in filings since 2020
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
FDA approved Paclitaxel on Aug 19, 2025, 8 days before this trade.
Generic drug approved. Active ingredient: Paclitaxel. From openFDA. Dates only; no link between the two is implied
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.6% | −2.2% | +0.6% |
| 30 days | −3.6% | +0.5% | −4.0% |
| 90 days | +16.0% | +9.0% | +7.0% |
| 180 days | +18.9% | +13.3% | +5.7% |
Past results only. Not a forecast.
Insider selling
Traded Mar 23 · filed 1 day laterNot reported under a pre-arranged trading plan
Viatris's See Remarks sold $284K of Viatris shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Mar 6 · filed 4 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Mar 6 · filed 4 days later
Routine share withholding; mechanical by default.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.